International Journal of Pharmacy Practice最新文献

{"title":"Regarding: Adverse drug reaction reporting by New Zealand pharmacists: a cross-sectional investigation of community and hospital pharmacists.","authors":"Lianne Parkin, Jennifer Lee, Ruth Savage, Susan Kenyon","doi":"10.1093/ijpp/riag097","DOIUrl":"https://doi.org/10.1093/ijpp/riag097","url":null,"abstract":"","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148758783","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Australian community pharmacists' comfort, attitudes, beliefs, and barriers regarding needle and syringe programs and correlates of provision: findings from a national study.","authors":"Louisa Picco, Rose Laing, Keiko Rice, Suzanne Nielsen, Monica Jung","doi":"10.1093/ijpp/riag106","DOIUrl":"https://doi.org/10.1093/ijpp/riag106","url":null,"abstract":"<p><strong>Objectives: </strong>To explore needle and syringe program (NSP) service provision and related correlates and comfort, attitudes, beliefs, and barriers to service provision, among a nationally representative sample of Australian community pharmacists.</p><p><strong>Methods: </strong>A national survey was undertaken between January and April 2025. The survey captured data on pharmacy and pharmacist characteristics, provision of NSP, and pharmacists' comfort, attitudes, beliefs, and barriers to providing NSP. Descriptive statistics and logistic regression models were used to determine the correlates of NSP provision and pharmacists' comfort with providing information about safer injection of heroin and stimulants.</p><p><strong>Key findings: </strong>Of the 643 pharmacists included in the analyses, 51.5% (n = 331) provided an NSP, with provision ranging from 35.0% in New South Wales to 82.1% in Western Australia. While most pharmacists providing NSPs believed that NSPs provide an opportunity to provide advice and referral to treatment services (56.2%) and education around the risks associated with illicit drug use/injecting drugs (59.0%), few pharmacists reported being comfortable providing information about safer injection of heroin (12.6%) and stimulants (12.7%). Reasons for not providing an NSP included a perceived lack of demand for the service (62.2%) and not enough monetary incentive (30.9%).</p><p><strong>Conclusions: </strong>Targeted initiatives are needed to strengthen community pharmacists' capacity to extend beyond needle and syringe provision to delivering harm reduction advice and referral. Addressing barriers, including perceived lack of demand and inadequate financial incentives, requires targeted policy support and sustainable funding to expand pharmacy-based NSPs.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-08-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148712415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Exploring health professionals' perspectives and preferences in the treatment of post-stroke fatigue and mental health disorders: an Australian qualitative vignette-based study.","authors":"Yuanchen Liang, Christopher Levi, Beata Bajorek","doi":"10.1093/ijpp/riag111","DOIUrl":"https://doi.org/10.1093/ijpp/riag111","url":null,"abstract":"<p><strong>Background: </strong>Post-stroke fatigue and mental health disorders are common but often overlooked. Health professionals' perspectives play a critical role in recognizing, assessing, and managing these symptoms, which significantly influence recovery and quality of life.</p><p><strong>Objectives: </strong>To explore health professionals' perspectives of post-stroke treatments and identify factors influencing treatment preferences.</p><p><strong>Methods: </strong>Vignette-based semi-structured interviews were conducted either in person or online/by telephone with health professionals, who were asked for their perspectives on four treatment vignettes using a 5-point Likert scale. Qualitative data were analysed thematically, and quantitative data were compared using non-parametric tests. Key themes were mapped to the Bio-Psycho-Social-Systems (BPSS) model to explore factors influencing treatment preferences.</p><p><strong>Key findings: </strong>Sixteen of 20 health professionals provided numerical ratings. There were no significant differences in 'liking' ratings for any fatigue or mental health vignette. CBT was most frequently the most preferred option for managing fatigue (90.0%), followed by modafinil (10.0%). For mental health, nortriptyline was most frequently the most preferred treatment (37.5%), followed by herbal medicines plus fluoxetine and acupuncture (25.0% each) and repetitive transcranial magnetic stimulation (12.5%). Five influencing themes were mapped to the BPSS model: therapeutic side effects and safety concerns (biological); evidence base and perceived efficacy (biological); accessibility and system practicality (systems); patient preferences (psychological/social); and professional scope and confidence (psychological/systems).</p><p><strong>Conclusion: </strong>Whilst health professionals were open to non-pharmacological strategies for managing post-stroke complications, conventional pharmacotherapy was preferred, either alone or in combination with other therapies, especially for severe mental health disorders.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-08-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148712461","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A nationwide survey of opioid stewardship programmes in Switzerland's hospitals.","authors":"Maurice Würsten, Carla Meyer-Massetti, Aljoscha N Goetschi","doi":"10.1093/ijpp/riag108","DOIUrl":"https://doi.org/10.1093/ijpp/riag108","url":null,"abstract":"<p><strong>Objectives: </strong>Opioid prescription counts are increasing across Europe and in Switzerland, yet inappropriate co-prescribing of opioids is common, with serious unintended clinical effects. There is limited information about the opioid stewardship programmes (OSPs) implemented in Europe and Switzerland. The present study surveyed OSPs in Switzerland's hospitals to characterize implemented OSPs and assessed their association with staffing.</p><p><strong>Methods: </strong>A 30-item questionnaire was sent to the director of every pharmacy in Switzerland's national hospital pharmacy association (n = 69). It addressed the pharmacy-reported use of seven types of OSP previously identified in the literature: automated decision support, opioid use guidelines, staff training, discussions of opioid issues/questions in committees, the availability of naloxone, interventions for appropriate opioid use and the monitoring of consumption.</p><p><strong>Key findings: </strong>Thirty-one of the 69 institutions completed the survey (45%) and a further nine responded partially (13%). Hospitals had implemented a median of three of the seven OSPs covered (interquartile range: 2-5). Infrequently implemented OSPs included alert systems to detect high-risk situations involving opioids (15%), opioid use guidelines (41%), education on safe opioid use (32%) and monitoring of opioid or naloxone use (42%). Committees on safe opioid use (59%) and clinical pharmacy interventions addressing safe opioid use (62%) were more frequently implemented. Naloxone was rapidly available in all institutions.</p><p><strong>Conclusions: </strong>Switzerland's hospitals rarely implement the seven types of OSPs identified, suggesting that more coordinated approaches to improving opioid safety are needed. Our interpretations should be treated cautiously, nevertheless, due to potential non-response bias.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148701284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Recruitment and retention of older people with dementia in clinical trials focused on evaluating the pharmacological management of the cognitive symptoms of dementia: a scoping review.","authors":"Bara'a Shawaqfeh, Carmel M Hughes, Bernadette McGuinness, Heather E Barry","doi":"10.1093/ijpp/riag107","DOIUrl":"https://doi.org/10.1093/ijpp/riag107","url":null,"abstract":"<p><strong>Objective: </strong>To investigate recruitment and retention of older people with dementia in clinical trials focused on evaluating pharmacological interventions for the treatment of cognitive symptoms of dementia.</p><p><strong>Methods: </strong>A scoping review conducted using Joanna Briggs Institute methodological guidance. A systematic search of five databases and the International Clinical Trials Registry Platform was conducted from inception to July 2023, and updated in January 2025. Randomised controlled trials of any type in English were eligible if they included people ≥65 years, with a dementia diagnosis (any sub-type/stage), focused on pharmacological management of cognitive symptoms of dementia in any setting. Following screening and data extraction, findings were tabulated descriptively to present study characteristics and approaches to recruitment and retention.</p><p><strong>Key findings: </strong>131 trials were included. Reasons for participant exclusion were having no carer present (n = 131 studies), and using specific medications such as anticholinergics (n = 28 studies). A small number of studies (n = 12) provided limited details on recruitment approaches. Recruitment strategies ranged from clinical referrals by investigators and treating physicians to community advertising and the re-engagement of previous trial participants. Reporting of retention approaches was limited across included studies. The mean sample size was 427 participants, and the mean retention rate was 75.4%, with adverse events, carer unavailability and withdrawal of consent among the most commonly reported reasons for discontinuation.</p><p><strong>Conclusions: </strong>Trials involving older people with dementia may not provide generalisable findings due to recruitment and retention challenges. Future research should focus on overcoming these challenges and clearly reporting strategies that may be of benefit to other researchers.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148701297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Empowering community pharmacists in colorectal cancer screening: a socio-ecological framework for action.","authors":"Chee Tao Chang, Xin Jie Lim, Chii Chii Chew, Shiau Hueh Yeow, Philip Rajan","doi":"10.1093/ijpp/riag105","DOIUrl":"https://doi.org/10.1093/ijpp/riag105","url":null,"abstract":"","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148689208","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Mapping quality indicators for pharmacist-led clinical services in community pharmacy: a scoping review.","authors":"Kerry Wilbur, Doua Ismail, Tracy Shu, Mark Makowsky, Marie-Laurence Tremblay, Emily Black, Jason Perepelkin, Nardine Nakhla","doi":"10.1093/ijpp/riag103","DOIUrl":"https://doi.org/10.1093/ijpp/riag103","url":null,"abstract":"<p><strong>Objectives: </strong>The expansion of community pharmacist scopes of practice requires quality definitions and measurements suitable to assess community pharmacist-led clinical services that are distinct from dispensing processes. This review identifies quality measurement tools or individual performance indicators applicable to community pharmacist-led clinical services.</p><p><strong>Methods: </strong>A scoping review was conducted according to the Arksey & O'Malley framework. A structured search of MEDLINE and EMBASE and grey literature was conducted for eligible records published between 2004 to December 2025 without language restriction. Title and abstract screening and full-text data extraction was independently performed by at least two reviewers. Content analysis was used to summarize the main findings.</p><p><strong>Key findings: </strong>Twenty-three articles were included of 1579 total records screened and reviewed. Most studies (n = 17) were conducted in Europe or North America. The six characterized community pharmacist-led clinical services were: (1) medication reviews; (2) appropriate medication use; (3) population-specific care; (4) common or minor ailment prescribing; (5) general community pharmacy practice; and (6) patient satisfaction. Fourteen studies described quality measurement tool development, and nine studies applied indicators to measure quality of care. Publications reported indicators emphasizing process outcomes (n = 23) while fewer reported structure (n = 13) or outcomes (n = 12). Few quality indicator sets addressed all established dimensions of quality.</p><p><strong>Conclusion: </strong>Currently available quality indicator sets do not comprehensively assess the various domains of quality for contemporary community pharmacist-led clinical services. Our review highlights conceptual patterns, gaps, and implications for required future indicator development.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148689128","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Expanding the role of pharmacists as vaccinators in New Zealand: a retrospective analysis of influenza vaccination trends following policy change.","authors":"Anna Larson, Rachel Mitrovich, Isabel Musse, Aimee J Lansdale, Amanda L Eiden","doi":"10.1093/ijpp/riag102","DOIUrl":"https://doi.org/10.1093/ijpp/riag102","url":null,"abstract":"<p><strong>Objectives: </strong>Pharmacy-based influenza vaccination became part of New Zealand's public vaccination programme in 2017, eliminating out-of-pocket costs to consumers. This study evaluated trends in pharmacy-based influenza vaccination among adults aged ≥65 in New Zealand following the 2017 funding policy change, with the aim of examining whether the availability of government-funded influenza vaccination increased pharmacy-based vaccination in this population.</p><p><strong>Methods: </strong>Data on influenza vaccinations administered between 2015 and 2021 to adults ≥65 were provided by the New Zealand Ministry of Health from the National Immunisation Register. Descriptive analyses were employed to assess the absolute number and percentage of vaccinations given by each provider type from 2015 through 2021 to document trends after the public funding policy change and in the early years of the COVID-19 pandemic.</p><p><strong>Key findings: </strong>The total number of influenza vaccinations administered increased from 322 161 in 2015 to 525 769 in 2021. After public funding for influenza vaccination began in pharmacies, annual physician- and nurse-administered vaccinations ranged from 401 840 to 426 005 and 12 590 to 19 586, respectively, between 2018 and 2021, while pharmacist-administered vaccinations steadily increased from 16 042 to 96 343. The percentage of influenza vaccinations administered by pharmacists grew from nearly 0% in 2015 to 3.7% in 2018 and 18.3% in 2021.</p><p><strong>Conclusions: </strong>Research findings suggest that public funding for pharmacist-administered influenza vaccinations contributed to expanding overall influenza vaccine access in New Zealand among adults ≥65. In addition, the increase in pharmacist-delivered vaccinations did not negatively impact vaccinations administered by traditional providers, further demonstrating the value and growing role of pharmacies in advancing national immunization efforts.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148678675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Factors influencing patient preferences for pharmacological and non-pharmacological treatment options in chronic health conditions: a systematic review.","authors":"Yuanchen Liang, Christopher Levi, Beata Bajorek","doi":"10.1093/ijpp/riag104","DOIUrl":"https://doi.org/10.1093/ijpp/riag104","url":null,"abstract":"<p><strong>Background: </strong>Understanding patient preferences is vital for promoting person-centred care, treatment adherence, and better health outcomes. Preferences across pharmacological and non-pharmacological therapies may be influenced by a range of personal and contextual factors, but they are seldom explicitly described and considered in treatment recommendations.</p><p><strong>Aims: </strong>To review the factors influencing patient preferences for various treatment options across a range of chronic health conditions.</p><p><strong>Methods: </strong>A systematic review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 guidelines. Literature was searched across Google Scholar, PubMed, EMBASE, CINAHL, and Medline (inception to April 2025), including English-language studies examining patient preferences for pharmacological and non-pharmacological treatment options in chronic health conditions. Studies were screened against predefined criteria and synthesized narratively.</p><p><strong>Results: </strong>Seventeen studies were identified, involving persons diagnosed with osteoporosis, stroke, depression, early cancer, acute myeloid leukemia or advanced myelodysplastic syndrome, multiple chronic diseases, and people in aged care. Factors influencing preferences included sex/gender, age, beliefs (e.g. health conditions, treatment), ethnicity and culture, economic concerns, prior treatment experiences, perceptions of treatment safety and effectiveness, accessibility, interaction with healthcare providers, and family and social support. Among these, age was the most common influencer, with older adults more likely to prefer non-pharmacological strategies. Sex/gender also shaped preferences; females/women were more inclined toward non-pharmacological strategies. Ethnocultural beliefs were linked to increased use of complementary and alternative medicines. Furthermore, patients tended to prefer treatments they perceived as having fewer side-effects and greater long-term efficacy. Alignment with patients' preferred treatments was associated with greater satisfaction and improved clinical outcomes.</p><p><strong>Conclusion: </strong>This review underscores the multifactorial nature of patient preferences, shaped by demographics, culture, and perceptions. These findings highlight the importance of considering patient preferences in clinical trials and when developing treatment guidelines.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148678692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Implementation of clinical pharmacy services in an adult medical intensive care unit at a French university hospital and the ICU team's perception of the pharmacist's role.","authors":"Alexandra Plesa, Keyvan Razazi, Loriane Viault, Nicolas De Prost, Guillaume Carteaux, Laura Bouabdallah-Perrin, Valérie Archer, Muriel Paul, Armand Mekontso Dessap, Clément Ourghanlian","doi":"10.1093/ijpp/riaf115","DOIUrl":"10.1093/ijpp/riaf115","url":null,"abstract":"<p><strong>Objectives: </strong>Clinical pharmacists are integral members of multidisciplinary teams in intensive care units (ICUs); however, their presence remains uncommon in French ICUs. This study aimed to describe clinical pharmacy activities implemented in a university hospital's adult medical ICU and assess the ICU team's perception of this implementation, its impact on practice and the pharmacist's role in ICU.</p><p><strong>Methods: </strong>This single-centre study covered a 6-month residency rotation. A pharmacy resident participated in daily rounds and reviewed prescriptions. Pharmacist interventions (PIs) were categorized using adapted codification. A cross-sectional survey conducted over 2 days evaluated the ICU team's views on clinical pharmacist practice interactions and future service requirements.</p><p><strong>Key findings: </strong>The pharmacy resident provided direct patient care (e.g. pharmacotherapy and drug-related problems; 86.4%, n = 393/455); and indirect services (e.g. computerized prescribing templates implementation, research support, and pharmacotherapy education for ICU staff; 13.6%, n = 62/455). Most PIs were optimizations (74.7%, n = 340/455) compared with medication error rectifications (25.3%, n = 115/455), with a high acceptance rate for prescription-related PIs (89.3%; n = 351/393). Of all PIs, 44.4% (n = 202/455) were solicited by the ICU team. Survey results showed 100% (n = 30) of the medical team and 71% (n = 15/21) of nurses believed the pharmacy resident's presence improved the ICU's training programme. Key pharmacist services included participation in rounds, managing adverse drug events, and updating pharmacotherapy protocols.</p><p><strong>Conclusions: </strong>This study illustrates a pharmacy resident's diverse services in ICU through medication error rectification, prescription optimization and indirect patient care. The ICU team valued this contribution, emphasizing the need for further integration of pharmacy services in French ICUs.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":"417-424"},"PeriodicalIF":2.5,"publicationDate":"2026-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145587219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}